These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3122798)

  • 21. Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs.
    Verrotti A; Greco R; Morgese G; Chiarelli F
    Int J Clin Lab Res; 1999; 29(1):36-40. PubMed ID: 10356662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum and urine total, free and acylcarnitine levels related to age: assessment of renal handling of carnitine.
    Güneral F
    Turk J Pediatr; 1995; 37(3):217-22. PubMed ID: 7502358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carnitine levels in valproic acid-treated psychiatric patients: a cross-sectional study.
    Moreno FA; Macey H; Schreiber B
    J Clin Psychiatry; 2005 May; 66(5):555-8. PubMed ID: 15986510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Valproic acid free fraction in epileptic children under chronic monotherapy.
    Riva R; Albani F; Franzoni E; Perucca E; Santucci M; Baruzzi A
    Ther Drug Monit; 1983 Jun; 5(2):197-200. PubMed ID: 6410546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valproate therapy does not deplete carnitine levels in otherwise healthy children.
    Hirose S; Mitsudome A; Yasumoto S; Ogawa A; Muta Y; Tomoda Y
    Pediatrics; 1998 May; 101(5):E9. PubMed ID: 9565442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative stress in children receiving valproic acid.
    Michoulas A; Tong V; Teng XW; Chang TK; Abbott FS; Farrell K
    J Pediatr; 2006 Nov; 149(5):692-6. PubMed ID: 17095346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ammonia and carnitine concentrations in children treated with sodium valproate compared with other anticonvulsant drugs.
    Thom H; Carter PE; Cole GF; Stevenson KL
    Dev Med Child Neurol; 1991 Sep; 33(9):795-802. PubMed ID: 1936631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal handling of carnitine in children with carnitine deficiency and hyperammonemia associated with valproate therapy.
    Matsuda I; Ohtani Y; Ninomiya N
    J Pediatr; 1986 Jul; 109(1):131-4. PubMed ID: 3088240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary medium-chain acylcarnitines in medium-chain acyl-CoA dehydrogenase deficiency, medium-chain triglyceride feeding and valproic acid therapy: sensitivity and specificity of the radioisotopic exchange/high performance liquid chromatography method.
    Schmidt-Sommerfeld E; Penn D; Rinaldo P; Kossak D; Li BU; Huang ZH; Gage DA
    Pediatr Res; 1992 Jun; 31(6):545-51. PubMed ID: 1635814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential excretion of xenobiotic acyl-esters of carnitine due to administration of pivampicillin and valproate.
    Melegh B; Kerner J; Jaszai V; Bieber LL
    Biochem Med Metab Biol; 1990 Feb; 43(1):30-8. PubMed ID: 2106908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicity of valproic acid in mice with decreased plasma and tissue carnitine stores.
    Knapp AC; Todesco L; Beier K; Terracciano L; Sägesser H; Reichen J; Krähenbühl S
    J Pharmacol Exp Ther; 2008 Feb; 324(2):568-75. PubMed ID: 17986647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of short- and long-term treatment with valproate on carnitine homeostasis in humans.
    Morand R; Todesco L; Donzelli M; Fischer-Barnicol D; Mullen PJ; Krähenbühl S
    Ther Drug Monit; 2012 Aug; 34(4):406-14. PubMed ID: 22743351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of carnitine on the metabolism of valproic acid in epileptic patients.
    Sakemi K; Hayasaka K; Tahara M; Sanada Y; Takada G
    Tohoku J Exp Med; 1992 Jun; 167(2):89-92. PubMed ID: 1475789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma and urine carnitine levels during development.
    Battistella PA; Vergani L; Donzelli F; Rubaltelli FF; Angelini C
    Pediatr Res; 1980 Dec; 14(12):1379. PubMed ID: 7193844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Valproic acid impairs carnitine uptake in cultured human skin fibroblasts. An in vitro model for the pathogenesis of valproic acid-associated carnitine deficiency.
    Tein I; DiMauro S; Xie ZW; De Vivo DC
    Pediatr Res; 1993 Sep; 34(3):281-7. PubMed ID: 8134167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Assay of carnitine in plasma and urine of healthy adults].
    Niu YJ; Jiang ZM; Shu H; Li CF; Liu W; Yao GX; Jiang J; Li JQ; Longo A
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):185-7. PubMed ID: 12905800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feeding preterm infants with L-carnitine supplemented formula.
    Melegh B; Kerner J; Szücs L; Porpáczy Z
    Acta Paediatr Hung; 1990; 30(1):27-41. PubMed ID: 2107830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carnitinuria in rickets due to vitamin D deficiency.
    Dursun A; Aliefendioğlu D; Ozkan B; Coşkun T
    Turk J Pediatr; 2000; 42(4):278-80. PubMed ID: 11196742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma and urine pharmacokinetics of free and of short-chain carnitine after administration of carnitine in man.
    Segre G; Bianchi E; Corsi M; D'Iddio S; Ghirardi O; Maccari F
    Arzneimittelforschung; 1988 Dec; 38(12):1830-4. PubMed ID: 3245856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma and urinary carnitine and acylcarnitines in chronic fatigue syndrome.
    Jones MG; Goodwin CS; Amjad S; Chalmers RA
    Clin Chim Acta; 2005 Oct; 360(1-2):173-7. PubMed ID: 15967423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.